68P Evaluation of flat dosing for nivolumab (NIVO) + ipilimumab (IPI) in first-line (1L) unresectable malignant pleural mesothelioma (MPM): CheckMate 743 (CM 743)

A.S. Tsao,P. Baas,A. Nowak, G. Zalcman,N. Fujimoto,S. Peters, C. Baudelet, P. Aanur, M. Osawa, A. Tendolkar,Y.Feng,J. Sheng

Annals of Oncology(2020)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要